These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8589212)

  • 1. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species.
    Ravanat C; Freund M; Dol F; Cadroy Y; Roussi J; Incardona F; Maffrand JP; Boneu B; Drouet L; Legrand C
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):446-55. PubMed ID: 8589212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
    Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of coagulation and platelet activation during percutaneous mitral valvuloplasty.
    Fernández MA; Villa P; España F; Aznar J; Rincón de Arellano A; Cebolla R
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):581-5. PubMed ID: 9863705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species specific immunoassays to measure blood platelet and coagulation activation in the rat.
    Ravanat C; Freund M; Schuhler S; Grunert P; Meyer L; Cazenave JP
    Thromb Haemost; 1996 Dec; 76(6):1090-5. PubMed ID: 8972036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension.
    Lekakis J; Triantafyllidi H; Galea V; Koutroumbi M; Theodoridis T; Komporozos C; Ikonomidis I; Christopoulou-Cokkinou V; Kremastinos DT
    J Thromb Thrombolysis; 2008 Apr; 25(2):179-84. PubMed ID: 17551668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation system and platelets are fully activated in uncomplicated sepsis.
    Mavrommatis AC; Theodoridis T; Orfanidou A; Roussos C; Christopoulou-Kokkinou V; Zakynthinos S
    Crit Care Med; 2000 Feb; 28(2):451-7. PubMed ID: 10708182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion.
    Skogby M; Friberg LG; Adrian K; Mellgren K
    Scand Cardiovasc J; 2003 Sep; 37(4):222-8. PubMed ID: 12944211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
    Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
    Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
    Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation and prothrombotic state parameters: clinical analysis in early pregnancy].
    Chen LB; Meng LL; Chen H; Du BJ; Zhu LQ; Gao L; Zhang JP; Tan JP
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(27):2146-8. PubMed ID: 24284247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.